Skip to content Skip to footer

Research Portal of the TU Dresden

Multiple sclerosis journal - experimental, translational and clinical

ISSNs: 2055-2173

Additional searchable ISSN (electronic): 2055-2173

Sage, London [u.a.], United States of America

Scopus rating (2022): CiteScore 3.9 SJR 0.714 SNIP 0.762

Journal

Titles	Multiple sclerosis journal - experimental, translational and clinical(2015 → …)
Additional searchable titles	Multiple Sclerosis Journal - Experimental, Translational and Clinical, MSJ - experimental, translational, clinical, MSJ-ETC
ISSNs	2055-2173
Additional searchable ISSN (electronic)	2055-2173
Publisher	Sage, London [u.a.]
Country/Territory	United States of America
ZDB-ID	2008225-3

Keywords

ASJC Scopus subject areas

Library keywords

610 Medicine and health

Related content

Research output

Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies

Dayan, C. M., Lecumberri, B., Muller, I., Ganesananthan, S., Hunter, S. F., Selmaj, K. W., Hartung, H-P., & 9 othersHavrdova, E. K., LaGanke, C. C., Ziemssen, T., Wijmeersch, B. V., Meuth, S. G., Margolin, D. H., Poole, E. M., Baker, D. P. & Senior, P. A., Jan 2023, In: Multiple sclerosis journal - experimental, translational and clinical. 9, 1

Research output: Contribution to journal › Research article › Contributed › peer-review

Comparing the long-term clinical and economic impact of ofatumumab versus dimethyl fumarate and glatiramer acetate in patients with relapsing multiple sclerosis: A cost-consequence analysis from a societal perspective in Germany

Koeditz, D., Frensch, J., Bierbaum, M., Ness, N-H., Ettle, B., Vudumula, U., Gudala, K., & 3 othersAdlard, N., Tiwari, S. & Ziemssen, T., Jan 2022, In: Multiple sclerosis journal - experimental, translational and clinical.

Research output: Contribution to journal › Research article › Contributed › peer-review

Timely intervention, monitoring and education MATTERS in MS (TIME MATTERS in MS): Development of a globally applicable quality improvement tool

Hobart, J., Butzkueven, H., Haartsen, J., Ziemssen, T., Lane, T. & Giovannoni, G., 2022, In: Multiple sclerosis journal - experimental, translational and clinical. 8, 3, p. 20552173221124023

Research output: Contribution to journal › Research article › Contributed › peer-review

Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS

Hersh, C. M., Kieseier, B., de Moor, C., Miller, D. M., Campagnolo, D., Williams, J. R., Fitzgerald, K. C., & 6 othersXiong, K., McGinley, M. P., Hyland, M., Rudick, R. A., Ziemssen, T. & Koulinska, I., 2021, In: Multiple sclerosis journal - experimental, translational and clinical. 7, 2, p. 20552173211004634

Research output: Contribution to journal › Research article › Contributed › peer-review

Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years

Horáková, D., Boster, A., Bertolotto, A., Freedman, M. S., Firmino, I., Cavalier, S. J., Jacobs, A. K., & 6 othersThangavelu, K., Daizadeh, N., Poole, E. M., Baker, D. P., Margolin, D. H. & Ziemssen, T., 2020, In: Multiple sclerosis journal - experimental, translational and clinical. 6, 4, p. 2055217320972137

Research output: Contribution to journal › Research article › Contributed › peer-review

View all research output (5)